REQUEST A DEMO
Total
USD $0.00
Search more companies

Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Dobryi Doctor 24 OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) is a company in Russia, with a head office in Shatura. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was incorporated on June 16, 2010. From the latest financial highlights, Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) reported a net sales revenue increase of 21.54% in 2024. Over the same period, its total assets grew by 13.43%. The net profit margin of Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) increased by 33.56% in 2024.

Headquarters
Iliicha, 55
Shatura; Moscow Oblast; Postal Code: 140704

Contact Details: Purchase the Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) report to view the information.
Financial Auditors:
Purchase the Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) report to view the information.
Incorporation Date:
June 16, 2010
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Dobryi Doctor 24 OOO (Добрый Доктор 24 ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
21.54%
Total operating revenue
21.54%
Operating profit (EBIT)
85.88%
Net Profit (Loss) for the Period
435.59%
Total Assets
13.43%
Total Equity
35.3%
Operating Profit Margin (ROS)
15.03%
Net Profit Margin
33.56%
Return on Equity (ROE)
19.44%
Debt/Equity
-5.52%
Quick Ratio
0.48%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?